Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents of HeartSciences Inc. from 30 Apr 2021 to 31 Jul 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Summary
HeartSciences Inc. quarterly Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents in USD history and change rate from 30 Apr 2021 to 31 Jul 2025.
  • HeartSciences Inc. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents for the quarter ending 31 Jul 2025 was $2,792,231, a 36% decline year-over-year.
Source SEC data
View on sec.gov
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Quarterly (USD)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, YoY Quarterly Change (%)

HeartSciences Inc. Quarterly Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $2,792,231 -$1,547,547 -36% 31 Jul 2025 10-Q 11 Sep 2025 2025 Q1
Q1 2025 $1,098,098 -$4,709,550 -81% 30 Apr 2025 10-Q 11 Sep 2025 2025 Q1
Q4 2024 $2,596,522 -$4,479,975 -63% 31 Jan 2025 10-Q 13 Mar 2025 2025 Q3
Q3 2024 $4,052,120 +$3,951,976 +3946% 31 Oct 2024 10-Q 16 Dec 2024 2025 Q2
Q2 2024 $4,339,778 +$3,764,124 +654% 31 Jul 2024 10-Q 11 Sep 2025 2025 Q1
Q1 2024 $5,807,648 +$4,147,181 +250% 30 Apr 2024 10-Q 11 Sep 2025 2025 Q1
Q4 2023 $7,076,497 +$5,145,545 +266% 31 Jan 2024 10-Q 13 Mar 2025 2025 Q3
Q3 2023 $100,144 -$2,975,822 -97% 31 Oct 2023 10-Q 16 Dec 2024 2025 Q2
Q2 2023 $575,654 -$3,502,066 -86% 31 Jul 2023 10-Q 12 Sep 2024 2025 Q1
Q1 2023 $1,660,467 +$742,207 +81% 30 Apr 2023 10-K 24 Jul 2025 2025 FY
Q4 2022 $1,930,952 +$602,744 +45% 31 Jan 2023 10-Q 14 Mar 2024 2024 Q3
Q3 2022 $3,075,966 +$2,705,587 +730% 31 Oct 2022 10-Q 14 Dec 2023 2024 Q2
Q2 2022 $4,077,720 +$4,071,730 +67975% 31 Jul 2022 10-Q 14 Sep 2023 2024 Q1
Q1 2022 $918,260 +$194,779 +27% 30 Apr 2022 10-K 29 Jul 2024 2024 FY
Q4 2021 $1,328,208 31 Jan 2022 10-Q 16 Mar 2023 2023 Q3
Q3 2021 $370,379 31 Oct 2021 10-Q 15 Dec 2022 2023 Q2
Q2 2021 $5,990 31 Jul 2021 10-Q 12 Sep 2022 2023 Q1
Q1 2021 $723,481 30 Apr 2021 10-K 19 Jul 2023 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.